QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online November 19, 2008
doi: 10.1242/jcs.039537

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Storchova, Z. Articles by Kuffer, C. Search for Related Content PubMed PubMed Citation Articles by Storchova, Z. Articles by Kuffer, C. Social Bookmarking                         What's this?

The consequences of tetraploidy and aneuploidy

Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany

^* Author for correspondence (e-mail: storchov{at}biochem.mpg.de)

Accepted 16 October 2008

Polyploidy, an increased number of chromosome sets, is a surprisingly common phenomenon in nature, particularly in plants and fungi. In humans, polyploidy often occurs in specific tissues as part of terminal differentiation. Changes in ploidy can also result from pathophysiological events that are caused by viral-induced cell fusion or erroneous cell division. Tetraploidization can initiate chromosomal instability (CIN), probably owing to supernumerary centrosomes and the doubled chromosome mass. CIN, in turn, might persist or soon give way to a stably propagating but aneuploid karyotype. Both CIN and stable aneuploidy are commonly observed in cancers. Recently, it has been proposed that an increased number of chromosome sets can promote cell transformation and give rise to an aneuploid tumor. Here, we review how tetraploidy can occur and describe the cellular responses to increased ploidy. Furthermore, we discuss how the specific physiological changes that are triggered by polyploidization might be used as novel targets for cancer therapy.

Key words: Aneuploidy, Chromosomal instability, Tetraploidy

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. J. E. Suijkerbuijk, M. H. J. van Osch, F. L. Bos, S. Hanks, N. Rahman, and G. J. P. L. Kops Molecular Causes for BUBR1 Dysfunction in the Human Cancer Predisposition Syndrome Mosaic Variegated Aneuploidy Cancer Res., June 15, 2010; 70(12): 4891 - 4900. [Abstract] [Full Text] [PDF]

				H. T. Ma, Y. H. Tsang, M. Marxer, and R. Y. C. Poon Cyclin A2-Cyclin-Dependent Kinase 2 Cooperates with the PLK1-SCF{beta}-TrCP1-EMI1-Anaphase-Promoting Complex/Cyclosome Axis To Promote Genome Reduplication in the Absence of Mitosis Mol. Cell. Biol., December 15, 2009; 29(24): 6500 - 6514. [Abstract] [Full Text] [PDF]

				M. Li, X. Fang, Z. Wei, J. P. York, and P. Zhang Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice J. Cell Biol., June 15, 2009; 185(6): 983 - 994. [Abstract] [Full Text] [PDF]

				A. Hoglund, L. M. Nilsson, L. P. Forshell, K. H. Maclean, and J. A. Nilsson Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine Blood, April 30, 2009; 113(18): 4281 - 4288. [Abstract] [Full Text] [PDF]